6 Einträge gefunden

1. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections

   1. Dietz, Julia
   2. Spengler, Ulrich
   3. Müllhaupt, Beat
   4. Schulze Zur Wiesch, Julian
   5. Piecha, Felix
   6. Mauss, Stefan
   7. Seegers, Barbara

   2021 - Forschungsinformationssystem des UKE
2. Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

   1. Dietz, Julia
   2. Kalinina, Olga V
   3. Vermehren, Johannes
   4. Peiffer, Kai-Henrik
   5. Matschenz, Katrin
   6. Buggisch, Peter
   7. Niederau, Claus

   2020 - Forschungsinformationssystem des UKE
3. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

   1. Dietz, Julia
   2. Susser, Simone
   3. Vermehren, Johannes
   4. Peiffer, Kai-Henrik
   5. Grammatikos, Georgios
   6. Berger, Annemarie
   7. Ferenci, Peter

   2018 - Forschungsinformationssystem des UKE
4. Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2013 - Forschungsinformationssystem des UKE
5. Faldaprevir and deleobuvir for HCV genotype 1 infection

   1. Zeuzem, Stefan
   2. Soriano, Vincent
   3. Asselah, Tarik
   4. Bronowicki, Jean-Pierre
   5. Lohse, Ansgar W
   6. Müllhaupt, Beat
   7. Schuchmann, Marcus

   2013 - Forschungsinformationssystem des UKE
6. Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.

   1. Zeuzem, Stefan
   2. Asselah, Tarik
   3. Angus, Peter
   4. Zarski, Jean-Pierre
   5. Larrey, Dominique
   6. Müllhaupt, Beat
   7. Gane, Ed

   2011 - Forschungsinformationssystem des UKE